Literature DB >> 6121299

The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.

M K Gaitonde, L P Lewis, G Evans, A Clapp.   

Abstract

The brains of rats paralysed at 4 hr after the administration of 6-aminonicotinamide were found to contain decreased levels of glutamate and gamma-aminobutyrate. The glucose content of the brain of the treated rats was several fold higher than in controls. The incorporation of 14C into brain amino acids at 30 min after the injection of [U-14C]glucose was decreased by 16%: this was attributed to mainly decreased labeling of glutamate and associated amino acids. The results are discussed in the light of previous findings that the administration of 6-aminonicotinamide resulted in the blockade of the direct oxidation of glucose by the pentose phosphate pathway.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6121299     DOI: 10.1007/bf00964420

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Inhibition of NADP dependent oxidoreductases by the 6-aminonicotinamide analogue of NADP.

Authors:  E Köhler; H -J. Barrach; D Neubert
Journal:  FEBS Lett       Date:  1970-02-16       Impact factor: 4.124

2.  Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine.

Authors:  M K Gaitonde; N A Fayein; A L Johnson
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

3.  [THE ACTIVITY OF NAD AND NADP-DEPENDENT ENZYMES IN DIFFERENT SEGMENTS OF THE RAT BRAIN].

Authors:  A BRUNNEMANN; H COPER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-03-19

4.  Pyridine nucleotide metabolism: mechanism of action of the niacin antagonist, 6-aminonicotinamide.

Authors:  L S DIETRICH; I M FRIEDLAND; L A KAPLAN
Journal:  J Biol Chem       Date:  1958-10       Impact factor: 5.157

5.  Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in animal tissues.

Authors:  G E GLOCK; P MCLEAN
Journal:  Biochem J       Date:  1955-11       Impact factor: 3.857

6.  Reaction of pyridine nucleotide analogues with dehydrogenases.

Authors:  M M CIOTTI; N O KAPLAN; F E STOLZENBACH
Journal:  J Biol Chem       Date:  1956-08       Impact factor: 5.157

7.  Direct oxidation of glucose-6-phosphate, 6-phosphogluconate and pentose-5-phosphates by enzymes of animal origin.

Authors:  F DICKENS; G E GLOCK
Journal:  Biochem J       Date:  1951-11       Impact factor: 3.857

8.  [Brain carbohydrate metabolism following blockade of the pentose phosphate pathway by 6-aminonicotinamide].

Authors:  K Lange; H Kolbe; K Keller; H Herken
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-10

9.  Contribution of the pentose cycle to the metabolism of glucose in the isolated, perfused brain of the monkey.

Authors:  K Y Hostetler; B R Landau; R J White; M S Albin; D Yashon
Journal:  J Neurochem       Date:  1970-01       Impact factor: 5.372

10.  The pentose phosphate pathway of glucose metabolism. Measurement of the non-oxidative reactions of the cycle.

Authors:  F Novello; P McLean
Journal:  Biochem J       Date:  1968-05       Impact factor: 3.857

View more
  3 in total

1.  Decreased labeling of amino acids by inhibition of the utilization of [3H, 14C]glucose via the hexosemonophosphate shunt in rat brain in vivo.

Authors:  M K Gaitonde; M D James; G M Evans
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

2.  Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats.

Authors:  P J Langlais; R G Mair; C D Anderson; W J McEntee
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

3.  The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.

Authors:  M K Gaitonde; G M Evans
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.